Learn how AI in drug discovery is revolutionizing therapeutic development and addressing challenges in cell and gene therapy.

The global drug discovery services market is projected to grow at a CAGR of 15% from 2025 to 2030. This growth is driven by ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Phenotypic screening has re-emerged as a powerful strategy for identifying drugs based on their observable effects. Discover ...

Intellomx announces its' new Pilot platform, delivering rapid identification of novel drugs arising from its therapeutic ...

Explore the evolving landscape of clinical trials in drug discovery and learn about recent breakthroughs transforming the ...

Chem, a global leader in DNA-encoded library (DEL) technology and data-driven drug discovery, has announced an expanded ...

"Enchant is an exceptionally powerful multimodal transformer model for drug discovery and development," said Fred Manby, Ph.D., Co-Founder and CTO of Iambic. "Enchant was created to make ...

Recursion Pharmaceuticals could benefit from FDA’s AI shift despite risks, with scalable tech and long-term potential. Find ...